Fresenius Loses 'Unduly Speculative' Generic Drug Row
A New Jersey federal judge on Tuesday tossed Fresenius Kabi's antitrust suit against Par Pharmaceuticals, which alleged that the drug ingredient maker blocked it from marketing a generic version of an...To view the full article, register now.
Already a subscriber? Click here to view full article